Cormorant Private Healthcare Fund II, LP
SEC-identified person · CIK 1747677 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Moonlake Immunotherapeutics MLTX | Officer | filed 2023 - 2025 |
| Greenlight Biosciences Holdings, PBC GRNA | Officer | filed 2023 - 2023 |
| Erasca, Inc. ERAS | Director | filed 2021 - 2023 |
| Jade Biosciences, Inc. JBIO | Officer | filed 2021 - 2021 |
| Monte Rosa Therapeutics, Inc. GLUE | Officer | filed 2021 - 2021 |
| Rain Therapeutics Inc. RAIN | Officer | filed 2021 - 2021 |
| Design Therapeutics, Inc. DSGN | Officer | filed 2021 - 2021 |
| Bioatla, Inc. BCAB | Officer | filed 2020 - 2020 |
| Olema Pharmaceuticals, Inc. OLMA | Officer | filed 2020 - 2020 |
| Atea Pharmaceuticals, Inc. AVIR | Officer | filed 2020 - 2020 |
| Akouos, Inc. AKUS | Officer | filed 2020 - 2020 |
| Avidity Biosciences, Inc. RNAM | Officer | filed 2020 - 2020 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.